Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722173 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Atopic Dermatitis: Generic Erosion Leads to Stagnant Market
Decision Resources, Inc., June 2006, Pages: 16

  Description  
  Table of Contents  

  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

Companies Mentioned Include:

- Altana
- Astellas
- Arachnova
- Aerovance
- Anacor Pharmaceuticals
- Connetics
- Clobetasol
- Corgentech
- Daiichi Sankyo
- Dainippon Sumitomo
- Kyowa
- Novartis
- ProMetic Life Sciences
- Pfizer
- Schering-Plough
- Sanofi-Aventis
- UCB
- York Pharma


Customers who bought this item also bought

Stakeholder Opinion: Atopic Dermatitis - A High Level of Unmet Need Creates Market Opportunities

Pipeline and Commercial Perspectives: Psoriasis and Atopic Dermatitis - Reimbursement the key as biologics and TIMs transform disease markets

Dermatology Seborrheic Dermatitis

Psoriasis - Biologics are Yet to Make Topical Treatments Obsolete

Seborrheic Dermatitis Therapy Area Pipeline Report

The Dermatology Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities

The Dermatology Market Outlook to 2011

Update on Dermatology Market

U.S. Topical Hemostats and Tissue Sealants Markets

Autoimmune Treatment (2009 - 2014)

Systemic Lupus Erythematosus Imprecise Segmentation Complicates Treatment Algorithms

Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents?
Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds